Table 1.
Characteristics of the newborns and samples.
Characteristics of the Neonates and Samples | ||||||||
---|---|---|---|---|---|---|---|---|
Phenotype | Number | Term | Sample Collection Date | |||||
23–32 weeks | 33–36 weeks | >37 weeks | 3–5 day | 6–10 day | 11–30 day | >30 day | ||
FS | 71 | 0 | 5 | 66 | 67 | 3 | 1 | 0 |
F/A | 2834 | 203 | 809 | 1822 | 2651 | 90 | 77 | 16 |
F/AC | 576 | 13 | 50 | 513 | 547 | 20 | 2 | 7 |
F/AE | 141 | 2 | 9 | 130 | 138 | 2 | 0 | 1 |
F/AO-Arab | 21 | 0 | 2 | 19 | 19 | 2 | 0 | 0 |
F/AD | 17 | 0 | 0 | 17 | 17 | 0 | 0 | 0 |
F/AKorle-Bu | 10 | 0 | 0 | 10 | 10 | 0 | 0 | 0 |
F/AX | 86 | 4 | 3 | 79 | 81 | 3 | 0 | 2 |
F/C | 7 | 0 | 1 | 6 | 6 | 0 | 0 | 1 |
F/E | 3 | 0 | 0 | 3 | 2 | 1 | 0 | 0 |
F/O-Arab | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
Corrected FA | 3696 | 222 | 874 | 2600 | 3472 | 118 | 79 | |
F/AS | 2894 | 57 | 247 | 2590 | 2763 | 89 | 23 | 19 |
F/SC | 23 | 0 | 1 | 22 | 22 | 1 | 0 | 0 |
F/SE | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
F/SO-Arab | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
Corrected FAS | 2919 | 57 | 249 | 2613 | 2787 | 90 | 23 | 19 |
S-β+-thalassaemia | 15 | 0 | 1 | 14 | 15 | 0 | 0 | 0 |
The number of corrected FA phenotype corresponding to the sum of all samples (FA, FAC, FAE, FAO-Arab, FAD, FAKorle-Bu, FAX, FC, FE, FO Arab where either βA gene was duplicated [βAβA] or associated with other β chain variants (βAβC, βAβE, βAβO-Arab, βAβD, βAβC, βAβX) or where duplicate ß chain variants were found (βCβC, βEβE, βO ArabβO-Arab) that are detected FA by MALDI. The number of corrected FAS phenotype corresponding to the sum of all heterozygous (FAS) and composite heterozygous (FSC, FSE, FSO-Arab) samples where βS gene was associated respectively to βA gene or to other ß chain variants (βSβC, βSβE, βSβO-Arab) that are detected FAS by MALDI.